Delayed management of giant omphalocele using silver sulfadiazine cream: an 18-year experience

Ein, Sigmund H.; Langer, Jacob C.

doi:10.1016/j.jpedsurg.2011.08.014

Cited by 66 publications

(53 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Bir kısım klinisyen defekt çapı 5 cm'den büyük ve kese içerisinde karaciğer varsa bunu dev omfalosel olarak tanımlarken (37) , bir kısmı da defekt çapının 10 cm'nin üzerinde olduğu olguları dev omfalosel olarak tanımlamaktadırlar (45) .…”

Section: Tedavi̇unclassified

See 1 more Smart Citation

Abdominal wall defects: omphalocele and gastrschisis

Yazıcı¹

2017

tcdd

View full text Add to dashboard Cite

show abstract

Section: Tedavi̇unclassified

“…Primer kapatılamayan büyük omfalosellerde başlan-gıçta konservatif tedavide gümüş sülfadiazin kreminin topikal kullanımı ve sonrasında oluşan ventral herninin onarımının uygun bir seçenek olduğu ileri sürmüşlerdir (37,45) .…”

Section: Tedavi̇unclassified

Abdominal wall defects: omphalocele and gastrschisis

Yazıcı¹

2017

tcdd

View full text Add to dashboard Cite

show abstract

“…Several studies verified the effectiveness of silver sulfadiazine in the treatment of omphalocele. 8,9 In a paper published by Lee et al, 18 22 omphalocele patients were conservatively treated by application with silver sulfadiazine. Median time to start enteral feeding was 4 days (range 1-19 days), and …”

Section: Delayed Repairmentioning

confidence: 99%

“…The rate of lung hypoplasia in a GO lies between 54% and 70%, with mortality rates reaching 30%-46%. 8,9 Whenever possible, primary surgical closure is the method of choice in treating these patients. There have been attempts in predicting feasibility of primary closure based on ratios of omphalocele diameter to biometric measures in prenatally diagnosed exomphalos.…”

Section: Introductionmentioning

confidence: 99%

Giant omphalocele: current perspectives

Mack¹,

Rogdo²

2016

RRN

View full text Add to dashboard Cite

Giant omphalocele (GO) is a congenital ventral abdominal wall defect characterized by a large opening with herniated abdominal organs, including liver, loss of abdominal cavity volume, and other associated congenital anomalies. Treatment of patients with GO represents a major challenge for involved caregivers. Despite significant improvements in neonatal intensive and surgical care over the last decades, the condition is still associated with high mortality rates and a high risk of severe morbidity in survivors. The principles of the earliest attempts to treat GO surgically and conservatively are still easily recognized in the main approaches used today. In this review, we discuss the more recent developments in the treatment of GO, including perioperative management and associated morbidities of the condition.

show abstract

“…More recently, some teams have successfully used zinc sulfadiazine cream in the waiting treatment of giant omphaloceles. The use of VAC therapy has been recommended for the waiting treatment of giant omphaloceles [8]. This is a technique used for the treatment of chronic wounds by creating negative pressure to the wound and it promotes formation of granulation tissue [4,9].…”

Section: Citationmentioning

confidence: 99%

Techniques and Results of the Conservative Treatment of Giant Omphalocele with 2% Disodium Aqueous Eosin

2014

Clinics in Mother and Child Health

View full text Add to dashboard Cite

Aim: Describe the techniques and results of the conservative treatment of giant omphalocele with aqueous eosin. Material and Methods:It was a 15 years conservative treatment retrospective study of giant omphalocele with 2% disodium eosin aqueous. The technique consisted of the twice a day application of 2% eosin on the omphalocele bag (sterile solution for cutaneous application). The technique was taught to the mother to continue with the outpatient care. We studied the duration of hospitalization, the learning curve of the technique through the mother, the intercurrent complications, the complete epithelialization percentage and the mortality.Results: A total number of 173 giant omphaloceles had a conservative treatment with 2% aqueous eosin. The average length of hospitalization was 21 ± 6 days. The learning curve of the application of the aqueous eosin on the bag omphalocele through the mother was 10 ± 3 days. Complications of treatment were 22% functional bowel obstruction and 18% infection of the omphalocele bag. The complete epithelialization of the omphalocele bag after the application of the 2% aqueous eosin was 68.5%. The mortality was observed in 25.5% of cases. Conclusion:The giant omphalocele conservative treatment with aqueous eosin is a simple, efficient technique and a good alternative to surgery. The learning through the mother reduces the length of hospital stay.

show abstract

Delayed management of giant omphalocele using silver sulfadiazine cream: an 18-year experience

Cited by 66 publications

References 26 publications

Abdominal wall defects: omphalocele and gastrschisis

Abdominal wall defects: omphalocele and gastrschisis

Giant omphalocele: current perspectives

Techniques and Results of the Conservative Treatment of Giant Omphalocele with 2% Disodium Aqueous Eosin

Contact Info

Product

Resources

About